Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1

Title
Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1
Authors
Keywords
-
Journal
Expert Opinion on Drug Discovery
Volume 8, Issue 2, Pages 219-244
Publisher
Informa Healthcare
Online
2012-12-12
DOI
10.1517/17460441.2013.741580

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now